PDCD1 and neoplasm: When combining PC7A nanoparticles with anti‐PD‐1 checkpoint blockade therapy, they showed synergistic tumor inhibitory effects in TC‐1 tumor models.113 In another study, PEI was utilized as an adjuvant to enhance antigen immunogenicity by incorporating PEI onto a mesoporous silica microrod (MSR) (Figure6).